This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Breast cancer drug rejected by NICE
Trial backs low-dose dexamethasone
GE announces cancer drug collaboration
Human Genome Sciences and GSK present phase III study results at ACR
Negative opinion on the market authorisation application for intravenous iclaprim
Schizophrenia link to epilepsy drug
Novartis drug Tasigna meets primary endpoint in pivotal trial against Glivec
ACZ885 more effective than an injectable corticosteroid
Excellence in Epilepsy Journalism Award
Delay for new osteoporosis drug
Swine flu may increase MRSA cases
Data at ACR shows rapid and sustained response for patients with RA
« Previous
1
…
106
107
108
109
110
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: